SS Innovations International, Inc SSII
NASDAQ · United States · Health Technology
$2.70-0.05 (-1.82%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
The program began with a robotic left internal mammary artery ("LIMA") take-down performed by Dr. Brajmohan Singh and proctored by Dr. Lalit Malik, using the SSi Mantra advanced robotic surgical system from SS Innovations. SS Innovations reported 23...
The company reported continued growth of its SSi Mantra surgical robotic system, with installations reaching 238 as of September 8, 2026, with the installed base now spanning 12 countries, following recent launches in Colombia and Sri Lanka and furt...
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
The company has supported the launch of Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo using the SSi Mantra 3.0 surgical robotic system. The program began with a robotic-assisted LIMA takedown, performed by SS Innovation...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.